Dr. William Trent Massengale, MD

Dr. Massengale practices at W Trent Massengale, MD in Prairieville, Louisiana.

Dr. Massengale's NPI, 1952398893, was assigned on October 5, 2005. Dr. Massengale graduated from Louisiana State University School of Medicine in New Orleans in 1996. Dr. Massengale holds Louisiana license 023151.

Dr. Massengale's primary practice is W Trent Massengale, MD, at 17503 Old Jefferson Hwy, Prairieville, LA 70769 in Ascension Parish. The practice phone is (225) 313-4560.

Dr. Massengale's primary practice is W Trent Massengale, MD in Prairieville, Louisiana. Dr. Massengale is also affiliated with Ochsner University Hospital & Clinics. The medical group on file is Atlas Dermatology. Dmand AI also links Dr. Massengale to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Massengale practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Massengale's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Massengale is licensed in Louisiana.

CMS data shows 2,633 Medicare services from Dr. Massengale across 18 procedure codes in 2024, for 603 Medicare patients. Medicare paid $116,448 for them. Every service was in an office.

CMS counts 603 Medicare patients who saw Dr. Massengale in 2024. The largest group is 65 to 74, with 347 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.88, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Massengale's median patient age at 67, with 47% women.

In 2024, Dr. Massengale wrote 1,932 Medicare Part D claims for 691 patients. 91% of them were for generic drugs. CMS names the drug for 1,791 of them, across 29 drugs with 11 or more claims each, at $786,013 in total drug cost. In 2023, CMS named 1,824 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Massengale for performance year 2024, reported individually. Dr. Massengale accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 927 procedures of removal of skin lesions by Dr. Massengale, more than 92% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Massengale in 2015. Dr. Massengale's most frequent co-author is Jill Huckabee Fruge, MD.

CMS Open Payments shows 1,626 general payments to Dr. Massengale from 49 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 80% of the total. Abbvie Inc. paid the most, $92,836.

Dr. Massengale graduated from Louisiana State University School of Medicine in New Orleans in 1996.